Suppr超能文献

美国黑人新用户中坚持进行线粒体小环状脱氧核糖核酸(mt-sDNA)检测用于结直肠癌筛查的情况。

Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population.

作者信息

Greene Mallik, Gohil Shrey, Camardo Mark, Ozbay A Burak, Limburg Paul, Lovelace Jerry

机构信息

Exact Sciences Corporation, Madison, Wisconsin, USA.

Nebraska Department of Correctional Services, Lincoln, Nebraska, USA.

出版信息

Curr Med Res Opin. 2025 Mar;41(3):513-520. doi: 10.1080/03007995.2025.2475074. Epub 2025 Mar 10.

Abstract

OBJECTIVE

Colorectal cancer (CRC) poses significant mortality risks, particularly among Black individuals, who experience the highest CRC incidence and mortality rates in the United States. This study examined adherence to multi-target stool DNA (mt-sDNA) testing in this population.

METHODS

This retrospective cohort analysis used Exact Sciences Laboratories (ESL)-linked claims data from January 2017 to December 2023 on Black patients in the United States aged 45 and older. High-risk individuals, those with payers other than commercial plans, managed care organizations, Medicare Advantage, Medicaid, or Medicare, and individuals with mt-sDNA prescriptions outside the study period were excluded. Adherence was defined as the percentage of patients returning the test kit with valid results within 365 days of shipment. Logistic regression analysis was used to identify factors associated with adherence.

RESULTS

Among 434,951 patients included in the study, the overall adherence to mt-sDNA testing was 62.0% ( = 266,981), with a mean time to adherence of 27.6 days (SD = 44.17). Females, older adults (76+ years), and non-metropolitan residents had higher adherence than males, younger adults, and metropolitan patients (all  < 0.001), respectively. Patients with orders from GI specialists had higher adherence than other prescribing clinicians (NP/PA: OR = 0.39, OB/GYN: OR = 0.54, Other: OR = 0.38, PCP: OR = 0.50; all  < 0.001). Digital outreach, especially SMS and email combination, was also associated with higher adherence (OR = 1.25,  < 0.001).

CONCLUSIONS

This large, national study found a 62.0% adherence rate to mt-sDNA testing among Black individuals. Higher adherence was associated with being female, older age, non-metropolitan residence, and digital outreach. While the findings highlight the promise of mt-sDNA, further research is needed to explore its full potential in improving CRC screening adherence across different demographic groups.

摘要

目的

结直肠癌(CRC)带来重大死亡风险,在美国,黑人的结直肠癌发病率和死亡率最高,风险尤为显著。本研究调查了该人群对多靶点粪便DNA(mt-sDNA)检测的依从性。

方法

这项回顾性队列分析使用了精确科学实验室(ESL)关联的2017年1月至2023年12月期间美国45岁及以上黑人患者的索赔数据。排除了高风险个体、有商业保险计划、管理式医疗组织、医疗保险优势计划、医疗补助计划或医疗保险以外的支付方的个体,以及在研究期间外有mt-sDNA处方的个体。依从性定义为在试剂盒发货后365天内返回有效检测结果的患者百分比。采用逻辑回归分析来确定与依从性相关的因素。

结果

在纳入研究的434,951名患者中,mt-sDNA检测的总体依从性为62.0%(n = 266,981),平均依从时间为27.6天(标准差 = 44.17)。女性、老年人(76岁及以上)和非大都市居民的依从性分别高于男性、年轻人和大都市患者(所有P < 0.001)。来自胃肠专科医生的医嘱患者的依从性高于其他开处方的临床医生(执业护士/医师助理:比值比 = 0.39,妇产科医生:比值比 = 0.54,其他:比值比 = 0.38,初级保健医生:比值比 = 0.50;所有P < 0.001)。数字推广,尤其是短信和电子邮件相结合的方式,也与更高的依从性相关(比值比 = 1.25,P < 0.001)。

结论

这项大规模的全国性研究发现,黑人对mt-sDNA检测的依从率为62.0%。更高的依从性与女性、年龄较大、非大都市居住以及数字推广有关。虽然研究结果凸显了mt-sDNA的前景,但仍需要进一步研究以探索其在提高不同人口群体结直肠癌筛查依从性方面的全部潜力。

相似文献

1
Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population.
Curr Med Res Opin. 2025 Mar;41(3):513-520. doi: 10.1080/03007995.2025.2475074. Epub 2025 Mar 10.
2
Real-World Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Among Asian Americans.
Cancer Control. 2025 Jan-Dec;32:10732748251330695. doi: 10.1177/10732748251330695. Epub 2025 Apr 1.
4
Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States.
Int J Colorectal Dis. 2025 Jan 17;40(1):16. doi: 10.1007/s00384-025-04805-0.
6
Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort.
Int J Colorectal Dis. 2021 Nov;36(11):2471-2480. doi: 10.1007/s00384-021-03956-0. Epub 2021 May 21.
7
Member Adherence to a Health Insurer-Sponsored Gap Closure Program Using Multi-Target Stool DNA Test for Colorectal Cancer Screening.
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241305958. doi: 10.1177/21501319241305958.
8
Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
Cancer Prev Res (Phila). 2021 Sep;14(9):845-850. doi: 10.1158/1940-6207.CAPR-21-0075. Epub 2021 May 21.
9
Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States.
Cancer Control. 2025 Jan-Dec;32:10732748251343334. doi: 10.1177/10732748251343334. Epub 2025 May 14.
10
Impact of Digital Navigation on Screening Adherence With the Multi-Target Stool DNA Test.
J Health Econ Outcomes Res. 2025 May 5;12(1):191-200. doi: 10.36469/001c.133939. eCollection 2025.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验